VERU INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 5.80% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-12-17
- VERU INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 5.80%.
- VERU INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.20%.
- VERU INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.10%.
- VERU INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.20%, a 116.67% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2025-09-30 | 5.80% 10-K · filed 2025-12-17 |
| 2024-09-30 | -0.20% 10-K · filed 2025-12-17 |
| 2023-09-30 | -0.10% 10-K · filed 2024-12-16 |
| 2022-09-30 | -0.20% 10-K/A · filed 2024-04-01 |
| 2021-09-30 | 1.20% 10-K · filed 2022-12-05 |
| 2020-09-30 | -0.20% 10-K · filed 2021-12-02 |
| 2019-09-30 | -0.40% 10-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |